However, nothing reminds you, so starkly, that these patients are living creatures than when your own family is diagnosed.
My mother, yesterday afternoon, was typed and staged: Stage IV Mantle-Cell Lymphoma, aggressively growing, with a typical presentation. She has splenic involvement and pleural effusion (meaning it is in the lungs).
- Lymphoma: Cancer of the lymph nodes; in this, the spleen is considered a lymph node, and not organ involvement
- Cancer: Uncontrolled growth and spread of abnormal cells, which have typically lost normal growth cycle regulation
- Stage IV: Abnormal cells have been found in several lymph nodes as well as either (A) organ involvement, or (B) specific symptoms unique to the specific diagnosis
- Aggressive: Fast-growing; slow-growing lymphomas are called "indolent"
- Mantle-Cell: MCL, a subtype of lymphoma
Mantle-cell lymphoma (MCL) is a form of Non-Hodgkin's lymphoma, stemming from abnormal B-lymphocytes. It is a fairly rare subtype of lymphoma, accounting for roughly 6% of NHL, and generally attacks men at a 3:1 ratio to women, usually aged in the late 50s and 60s.
Unfortunately, the prognosis isn't exactly heartwarming:
Mantle cell lymphoma is an aggressive Non-Hodgkin's lymphoma that historically been resistant to current standard chemotherapeutic approaches. Despite response rates to many regimens of 50% to 70%, the disease would progress after chemotherapy with a median survival time of approximately 2.5 to 4 years.
Time will tell. Until then, it's a constant reminder that my patients are sons and mothers and lovers, not just pathology incubators. I've always known this, especially when I bemoan a lonely, fussy baby whose parents would rather go outside and smoke, but even I forget the impact of losing that.
Resources:
http://www.lymphomainfo.net/nhl/types/mantle.html
http://www.leukemia-lymphoma.org/attachments/National/br_1172589724.pdf
0 comments:
Post a Comment